Discover how NRF2 drives metabolic reprogramming in pancreatic cancer cells, creating radioresistance and opening new avenues for treatment.
Exploring evidence-based complementary treatments for pancreatic cancer including paricalcitol, hydroxychloroquine, vitamin C, statins, metformin, curcumin, and aspirin.
Discover how PHD3 protein overexpression inhibits blood vessel formation in pancreatic cancer, creating a therapeutic paradox for treatment approaches.